Sector consensus Vanda Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 05/12/2025 GMT			5-day change	1st Jan Change
5.390 ^USD	+3.65%		+0.56%	+12.53%

12-04	Vanda Says FDA Lifts Partial Hold on Tradipitant Motion-Sickness Study	MT
12-04	FDA Lifts Hold on Vanda Pharmaceuticals' Motion Sickness Drug	DJ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
VANDA PHARMACEUTICALS INC.			US$11.75	+118%	4
ARGENX SE			€779.13	+1.05%	13
INSMED INCORPORATED			US$222.78	+9.2%	18
WUXI APPTEC CO., LTD.			CN¥125.98	+39.36%	19
BIONTECH SE			US$117.99	+43%	19
GENMAB A/S			DKK 2,054.66	+1.11%	14
WUXI BIOLOGICS (CAYMAN) INC.			HK$35.84	+20.96%	25
AKESO, INC.			HK$155.27	+37.74%	21
SUMMIT THERAPEUTICS INC.			US$24.26	+75.2%	13
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			HK$535.62	+16.44%	17
MADRIGAL PHARMACEUTICALS, INC.			US$563.8	-2.34%	15
EXELIXIS, INC.			US$44.94	+1.32%	18
NUVALENT, INC.			US$141.82	+29.4%	17
ARROWHEAD PHARMACEUTICALS, INC.			US$57.67	-6.14%	12
CYTOKINETICS, INCORPORATED			US$79.56	+21.14%	18
METSERA, INC.	-	-	-	-	-
MERUS N.V.		-	US$97	+0.89%	13
Average			315.5	+25.40%	16
Weighted average by Cap.			410.18	+18.81%	17